• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ECHO-7 溶瘤病毒 Rigvir 治疗 IIA 期皮肤黑色素瘤。

Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir.

机构信息

Institute of Stomatology, Rīga Stradiņš University, Riga, Latvia.

Oncology Centre of Latvia, Rīga East University Hospital, Riga, Latvia.

出版信息

Perm J. 2022 Sep 14;26(3):139-144. doi: 10.7812/TPP/21.232. Epub 2022 Aug 11.

DOI:10.7812/TPP/21.232
PMID:35950985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9683754/
Abstract

Melanoma is a global problem due to the rising numbers of skin melanoma cases. Current treatment guidelines for patients with stage IIA melanoma recommend only observation after surgery. In this report, the authors describe a patient with stage IIA skin melanoma treated with surgery and Rigvir virotherapy. Two years after the patient discovered a brown spot on the right cheek, surgery was indicated because the mass had started to ulcerate. Rigvir virotherapy was applied both before and after surgery. Observations made more than 7 years after surgery indicated no signs of disease progression. This case report illustrates an early treatment approach. Neoadjuvant treatment for early-stage melanoma is gaining more interest in both scientific and medical communities; therefore, the authors believe it is relevant to share their observations.

摘要

黑色素瘤是一个全球性问题,因为皮肤黑色素瘤病例的数量不断增加。目前对于 IIA 期黑色素瘤患者的治疗指南仅建议在手术后进行观察。在本报告中,作者描述了一位接受手术和 Rigvir 病毒疗法治疗的 IIA 期皮肤黑色素瘤患者。在患者发现右脸颊上有一个棕色斑点两年后,由于肿块开始溃疡,因此进行了手术。在手术前后都应用了 Rigvir 病毒疗法。手术后超过 7 年的观察表明没有疾病进展的迹象。本病例报告说明了一种早期治疗方法。新辅助治疗早期黑色素瘤在科学界和医学界都越来越受到关注;因此,作者认为分享他们的观察结果是相关的。

相似文献

1
Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir.ECHO-7 溶瘤病毒 Rigvir 治疗 IIA 期皮肤黑色素瘤。
Perm J. 2022 Sep 14;26(3):139-144. doi: 10.7812/TPP/21.232. Epub 2022 Aug 11.
2
Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study.一项回顾性研究表明,经改良的ECHO-7病毒Rigvir免疫疗法(溶瘤病毒疗法)可延长黑色素瘤患者肿瘤手术切除后的生存期。
Melanoma Res. 2015 Oct;25(5):421-6. doi: 10.1097/CMR.0000000000000180.
3
The advent of oncolytic virotherapy in oncology: The Rigvir® story.肿瘤溶瘤病毒治疗在肿瘤学中的应用:Rigvir®的故事。
Eur J Pharmacol. 2018 Oct 15;837:117-126. doi: 10.1016/j.ejphar.2018.08.042. Epub 2018 Sep 1.
4
Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports.一名IV期M1c黑色素瘤患者、一名IIIA期小细胞肺癌患者和一名IV期组织细胞肉瘤患者接受溶瘤ECHO-7病毒Rigvir的长期治疗——三例病例报告
APMIS. 2016 Oct;124(10):896-904. doi: 10.1111/apm.12576. Epub 2016 Jul 26.
5
Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines.溶瘤 ECHO-7 病毒株 Rigvir 对葡萄膜黑色素瘤细胞系的影响。
BMC Res Notes. 2020 Apr 16;13(1):222. doi: 10.1186/s13104-020-05068-4.
6
A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report.1例采用溶瘤性ECHO-7病毒治疗的进展期IIIB期黑色素瘤:病例报告
SAGE Open Med Case Rep. 2020 Jun 23;8:2050313X20934978. doi: 10.1177/2050313X20934978. eCollection 2020.
7
ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report.溶瘤病毒ECHO-7 Rigvir®用于I期葡萄膜黑色素瘤辅助治疗的回顾性病例报告
Am J Ophthalmol Case Rep. 2020 Jan 31;17:100615. doi: 10.1016/j.ajoc.2020.100615. eCollection 2020 Mar.
8
Cytolytic Properties and Genome Analysis of Rigvir Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates.溶细胞特性和基因组分析 Rigvir 溶瘤病毒治疗病毒和其他肠道病毒 7 分离株。
Viruses. 2022 Mar 4;14(3):525. doi: 10.3390/v14030525.
9
Oncolytic virus preclinical toxicology studies.溶瘤病毒临床前毒理学研究。
J Appl Toxicol. 2023 May;43(5):620-648. doi: 10.1002/jat.4408. Epub 2022 Nov 7.
10
A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir®.1例IV期嫌色细胞肾细胞癌采用溶瘤性ECHO-7病毒(Rigvir®)治疗的病例
Am J Case Rep. 2019 Jan 12;20:48-52. doi: 10.12659/AJCR.912115.

引用本文的文献

1
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges.癌症纳米免疫疗法的现状与未来:机遇、障碍与挑战
Mol Cancer. 2025 Jan 18;24(1):26. doi: 10.1186/s12943-024-02214-5.
2
Preliminary efficacy and safety of YSCH-01 in patients with advanced solid tumors: an investigator-initiated trial.YSCH-01 治疗晚期实体瘤患者的初步疗效和安全性:一项研究者发起的试验。
J Immunother Cancer. 2024 May 7;12(5):e008999. doi: 10.1136/jitc-2024-008999.
3
Oncolytic virotherapy: basic principles, recent advances and future directions.溶瘤病毒治疗:基本原则、最新进展和未来方向。
Signal Transduct Target Ther. 2023 Apr 11;8(1):156. doi: 10.1038/s41392-023-01407-6.

本文引用的文献

1
Cutaneous melanoma and the immunotherapy revolution (Review).皮肤黑色素瘤与免疫治疗革命(综述)。
Int J Oncol. 2020 Sep;57(3):609-618. doi: 10.3892/ijo.2020.5088. Epub 2020 Jun 25.
2
Oncolytic Viruses: Priming Time for Cancer Immunotherapy.溶瘤病毒:癌症免疫治疗的前奏。
BioDrugs. 2019 Oct;33(5):485-501. doi: 10.1007/s40259-019-00367-0.
3
Optimizing oncolytic virotherapy in cancer treatment.优化溶瘤病毒治疗癌症。
Nat Rev Drug Discov. 2019 Sep;18(9):689-706. doi: 10.1038/s41573-019-0029-0. Epub 2019 Jul 10.
4
Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis.肿瘤浸润淋巴细胞在黑色素瘤中的预后价值:一项系统评价和荟萃分析。
Oncoimmunology. 2019 Apr 3;8(7):1593806. doi: 10.1080/2162402X.2019.1593806. eCollection 2019.
5
The advent of oncolytic virotherapy in oncology: The Rigvir® story.肿瘤溶瘤病毒治疗在肿瘤学中的应用:Rigvir®的故事。
Eur J Pharmacol. 2018 Oct 15;837:117-126. doi: 10.1016/j.ejphar.2018.08.042. Epub 2018 Sep 1.
6
Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review.皮肤黑色素瘤——从实验模型到临床结果的漫长道路:综述。
Int J Mol Sci. 2018 May 24;19(6):1566. doi: 10.3390/ijms19061566.
7
Oncolytic Virotherapy and the Tumor Microenvironment.溶瘤病毒治疗与肿瘤微环境。
Adv Exp Med Biol. 2017;1036:157-172. doi: 10.1007/978-3-319-67577-0_11.
8
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.溶瘤病毒疗法可促进肿瘤内T细胞浸润并改善抗PD-1免疫疗法。
Cell. 2017 Sep 7;170(6):1109-1119.e10. doi: 10.1016/j.cell.2017.08.027.
9
Converting Cold into Hot Tumors by Combining Immunotherapies.免疫疗法联合将冷肿瘤转化为热肿瘤。
Cell. 2017 Sep 7;170(6):1055-1056. doi: 10.1016/j.cell.2017.08.031.
10
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.黑色素瘤前哨淋巴结转移的完全解剖或观察
N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.